Conclusion
the dossier summarised in one paragraphAOP Orphan Pharmaceuticals Belgium is younger than twelve months; there is no public track record yet to compute a bankruptcy probability from. The company has been active since 2025 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
Based on State Gazette and CBE data.
Financials
No processed annual-account figures available.
To financials
People & board
2 mandates
2
active directors
Bernhard NACHBAURDirectorMaarten MANDERSDirector
All directors & mandates Publicationslatest 12-06-2026
10
publications in the State GazettePublication in the Belgian Official Gazette — Minor changeAll publications & acts Network & structure
No network or structure data processed.
To structure
Trust signals
2 signalsYoung company
Founded in 2025 — under 3 years, statistically higher risk.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administrative Flags
1 eventUBO non-compliance
Bankruptcy probability (12 mo)
Checked model v1 · free for everyoneThis company is younger than 12 months. There is no public track record yet to base a reliable estimate on — so we'd rather not show a number.
Company registry (CBE)
Crossroads BankActivities
Groothandel in farmaceutische en medische artikelen46460
Primary activity highlighted.
Names & trade names
| Legal nameNL | AOP Orphan Pharmaceuticals Belgium |
Registered office
Slachthuisstraat 120 bus 18
2300 Turnhout, Belgium
Registration history
- 02-06-2026 Strikeout ubo initial
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.